Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Allergy News
Harrow Lowers Price of Drugs through GoodRx Partnership, Price Cuts
Harrow, of Nashville, Tennessee reported Nov. 13 that it had entered into a partnership with GoodRx to provide patients without insurance or for whom insurance is not a viable option a cash-pay alt...
Clinical Trial Updates for Ophthalmic Candidates, November 2024
Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.
Nicox Reports that Ocumension Has Gained Approval for Zerviate in China
France’s Nicox announced Sept. 18 that partner Ocumension Therapeutics had received regulatory approval in China to commercialize Nicox’ Zerviate (cetirizine ophthalmic solution) 0.24% for ocular i...
New OTC Eye Lubricants Available from AbbVie, Ocusoft
AbbVie has introduced two new preservative-free lubricant eye drop products—Refresh Tears PF and Refresh Relieva PF Xtra. AbbVie, of North Chicago, Illinois, said the new products feature a soft-sq...
Emerging Companies Pursuing Ophthalmic Indications, March 2024
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.
Regulators in Singapore Accept NDA from AffaMed for Dextenza
Shanghai-based AffaMed Therapeutics announced Feb. 19 that the Singapore Health Sciences Authority had accepted its new drug application (NDA) for Dextenza (0.4 mg dexamethasone intracanalicular in...
Harrow Licenses Rights to Five Drugs to Apotex for Canada
Harrow reported Feb. 15 that it had licensed to Apotex exclusive marketing and distribution rights to Verkasia and over-the-counter Cationorm Plus in the Canadian market. In addition, Apotex will p...
US FDA Approves Generic Loteprednol Etabonate Drops from India’s Lupin for Seasonal Allergy
Indian drugmaker Lupin announced Dec. 27 that the US FDA had approved its abbreviated new drug application for loteprednol etabonate ophthalmic suspension, 0.2%, a generic equivalent of Bausch + Lo...
Q2-2023 Ophthalmic Revenue Roundup for RxSight, LENSAR, Hoya, and Two Others
Japan-based Hoya Corporation announced July 31 that its medical care segment (IOLs, endoscopes, artificial bone) had revenue for the quarter ending June 30, 2023—the first quarter of its fiscal yea...
Clinical Trial Updates for Ophthalmic Candidates, July 2023
Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.